TLDR:
Calvin Goforth, chairman and CEO of VIC Technology Venture Development, shares an optimistic outlook on venture capital in 2024 despite challenges in fundraising. VIC focuses on creating life sciences companies and has seen significant progress in its portfolio companies. Goforth highlighted the company’s expansion, diversification of investments, and plans for future growth.
Key Points:
- Calvin Goforth optimistic about venture capital in 2024
- Challenges in fundraising overcome by VIC’s adaptability and perseverance
Calvin Goforth, chairman and CEO of VIC Technology Venture Development in Fayetteville, remains positive about the outlook for venture capital funding in 2024, emphasizing the progress made by VIC portfolio companies despite a challenging year for fundraising. While facing liquidity constraints and a closed IPO window, VIC has managed to support its companies through funding gaps and attract non-dilutive funding. The expansion of VIC’s innovation ecosystem, including programs like VIC Foundry, VIC Fellows, and the VIC Investor Network, has contributed to the company’s growth and success in the life sciences sector.
Goforth highlighted VIC’s achievements in securing funding for key portfolio companies, such as Calyxo, and emphasized the potential for high value growth across the portfolio. The VIC Investor Network continues to offer attractive valuations to investors, aiming to fuel expansion and support the formation of new companies in the coming year. Despite the risks associated with investing in early-stage life science companies, Goforth remains optimistic about the potential rewards and returns for investors.
